©2022 Stanford Medicine
Prevention of Persistent Opioid Use in Mothers
Not Recruiting
Trial ID: NCT03472521
Purpose
Our previous work has identified the group of women at risk for prolonged pain, opioid use
and poor functional recovery after childbirth. The optimal intervention to mitigate this risk
is unknown. We propose to test an analgesic adjutant that is commonly used for post-operative
pain compared to placebo to improve post-partum recovery.
Official Title
Prevention of Persistent Pain and Opioid Use in Mothers - POMS
Eligibility
Inclusion Criteria:
- Delivery within 5 days, able to provide informed consent, English speaker
Exclusion Criteria:
- Opiate use disorder
Intervention(s):
drug: Gabapentin
drug: Placebo
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Pamela Flood, MD, MA
201-370-3933